Skip to content

ETEST Ciprofloxacin

by Ab Biodisk Sweden 510(k)

510(k) K981138

Product code JWY

Overview

The ETEST Ciprofloxacin is a manual antimicrobial susceptibility test system designed to determine bacterial susceptibility to ciprofloxacin. Classified as a microbiology device, it provides quantitative measurement of minimum inhibitory concentrations (MICs) for bacterial isolates, aiding in the selection of appropriate antibiotic therapy. This gradient diffusion method uses plastic strips impregnated with ciprofloxacin to assess resistance patterns in clinical microbiology settings.

Supplied as a sterile, single-use device, the ETEST Ciprofloxacin is intended for use in clinical laboratories under controlled conditions. Each strip is individually packaged and requires no additional preparation beyond standard microbiological techniques. The device adheres to FDA 510(k) clearance (K981138) under product code JWY, falling under Class II special controls for manual antimicrobial susceptibility test systems. Storage and handling follow standard aseptic practices for microbiological reagents.

Summary written by AI from registry data, 20 Sep 2026.Not verified

About this summary

This description and any FAQs on this page were generated automatically and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK981138 Date5 Jun 1998ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Not covered

United States — FDA 510(k) Active

Recalls

1 recall · FDA

    • Terminated Z-1524-2017 FDA Class II initiated 15 Dec 2016

    Product Stability issues: The current shelf-life claims of the ETEST products are not supported by internal testing.

Specification

510(k) · synced 6 Oct 2026

510(k) Number
FDA Product Code
JWY
Device Class
Class II
Regulation
21 CFR Part 866.1640
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Other devices from Ab Biodisk

See all devices from Ab Biodisk →

Questions

  • What is the ETEST Ciprofloxacin used for in a clinical setting?

    The ETEST Ciprofloxacin is a manual antimicrobial susceptibility test system that determines how sensitive bacterial isolates are to the antibiotic ciprofloxacin. By measuring the minimum inhibitory concentration (MIC) through gradient diffusion, it helps clinicians select the most effective antibiotic therapy for treating infections caused by these bacteria.

  • Is the ETEST Ciprofloxacin single-use or reusable?

    The ETEST Ciprofloxacin is designed as a sterile, single-use device. Each strip is individually packaged and intended for one-time use in controlled clinical laboratory settings, ensuring accuracy and preventing cross-contamination.

  • How should the ETEST Ciprofloxacin strips be stored?

    The strips should be stored following standard aseptic practices for microbiological reagents. Since they are sterile and single-use, they must be kept in a clean, dry environment to maintain their integrity until use, avoiding exposure to moisture or contamination.

  • What regulatory pathway was followed for FDA clearance of the ETEST Ciprofloxacin?

    The ETEST Ciprofloxacin received FDA clearance through a traditional 510(k) review process (K981138) under product code JWY, classified as a Class II device under special controls for manual antimicrobial susceptibility test systems. The decision was made by the Microbiology (MI) Advisory Committee in 1998.

  • Do the ETEST Ciprofloxacin strips require any special preparation before use?

    No additional preparation beyond standard microbiological techniques is required. The strips are pre-packaged and ready for use, adhering to the gradient diffusion method without needing further handling or activation before application in testing.

Properties & raw data

Show properties, registry sources and raw records

Sources (1)

  • FDA 510(k) K981138 24 fields · synced 6 Oct 2026